1oy7

Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)

PDB structure
Accession
1oy7
Experiment typeX-ray
Resolution2.7 Å
ChainsA, B, C, D, E, F
Released26 August 2003

Chain A ( Q96CA5)

Domains in the chain

Chain B ( Q96CA5)

Domains in the chain

Chain C ( Q96CA5)

Domains in the chain

Chain D ( Q96CA5)

Domains in the chain

Chain E ( Q96CA5)

Domains in the chain

References

1. Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP) Franklin, M.C., Kadkhodayan, S., Ackerly, H., Alexandru, D., Distefano, M.D., Elliott, L.O., Flygare, J.A., Mausisa, G., Okawa, D.C., Ong, D., Vucic, D., Deshayes, K., Fairbrother, W.J. Biochemistry 42, 8223-8231, (2003). View articlePMID: 12846571

2. ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas Vucic, D., Stennicke, H.R., Pisabarro, M.T., Salvesen, G.S., Dixit, V.M. Curr. Biol. 10, 1359-1366, (2000). View article

3. SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP) Vucic, D., Deshayes, K., Ackerly, H., Pisabarro, M.T., Kadkhodayan, S., Fairbrother, W.J., Dixit, V.M. J. Biol. Chem. 277, 12275-12279, (2002). View article

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our Privacy Notice and Terms of Use.